The drug company has invested $19 million to scale up production of its antiviral drug, molnupiravir, at Thermo Fisher Scientific's facility in Whitby, Ont.
Chief Justice John Roberts and Justice Samuel Alito were among those who questioned the viability line, with Alito referencing those who have said the line "really doesn't make any sense.''